New Xarelto Lawsuits Given Direct Filing Privileges in MDL

Attorneys handling national Xarelto lawsuits alleging internal bleeding for the Onder Law Firm provide a news update on the multidistrict litigation for Xarelto lawsuit claims underway in Louisiana.

Tuesday, April 28, 2015 - New Xarelto lawsuits no longer need to be filed in federal district courts to be considered for inclusion in the national Xarelto multidistrict litigation*, according to a recent Pre-Trial order accessed by attorneys representing internal bleeding claims. These Xarelto attorneys provide regular news updates and no-cost Xarelto lawsuit case evaluation at XareltoContingencyLawsuit.com.

Direct Filing is a legal procedure that enables new cases making identical claims to be filed directly with a pending multidistrict litigation in order to eliminate delays and promote judicial efficiency, according to court documents. Persons who reside in the United States and who purchased Xarelto in the United States, may be eligible for this status, according to court documents.

Plaintiffs having already filed Xarelto lawsuits that have been consolidated for pretrial proceedings already number over 400, according to the Judicial Panel on Multidistrict Litigation‘s record. Each Xarelto case makes common allegations, saying the pharmaceutical company Janssen Research & Development knew or should have known of the increased risk of serious internal bleeding caused by Xarelto, according to court documents. Persons who have filed Xarelto lawsuits say they were not warned of the alleged bleeding risk, or the fact that there is no antidote to bleeding caused by Xarelto, according to court documents.

Xarelto lawsuits attempt to recover damages for individuals and families who have suffered or lost a loved one as a result of bleeding or another related medical condition they attribute to Xarelto. Attorneys handling Xarelto lawsuits throughout the United States are now accepting claims from persons and their loved ones who suffered from severe internal bleeding or hemorrhagic stroke while taking Xarelto. Lawyers are investigating these inquiries for possible Xarelto lawsuits. The Onder Law Firm is renowned for its achievements in product and consumer safety litigation, with a strong track record of winning meaningful settlements for clients. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful corporations. Individuals and the family members of individuals who have suffered from internal bleeding and have taken Xarelto are eligible for a no-cost, no-obligation Xarelto lawsuit case review, and may contact the firm through its Xarelto Contingency Lawsuit website.

The Onder Law Firm also welcomes Xarelto lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.

About The Onder Law Firm

Onder, Shelton, O‘Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O‘Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firms Xarelto attorneys provide information to the public at www.XareltoContingencyLawsuit.com.

*Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592, United States District Court, Eastern District of Louisiana

Other Xarelto Internal Bleeding Lawsuit Attorney News Releases:

Ad